糖尿病大鼠骨髓间充质干细胞成骨和成脂分化的研究
Study of Osteogenesis and Adipogenesis of Bone Marrow Mesenchymal Stem Cells by Diabetic Rats
DOI: 10.12677/ACM.2018.88125, PDF,    科研立项经费支持
作者: 陈 嘉, 余文兰, 马晓莉, 谢淑敏, 刘永伦:华南农业大学,实验动物中心,广东 广州
关键词: 糖尿病骨髓间充质干细胞成骨分化成脂分化骨质疏松大鼠Diabetes Bone Marrow Mesenchymal Stem Cells Osteogenesis Adipogenesis Osteoporosis The Rat
摘要: 目的:研究糖尿病模型大鼠造模后不同时间段骨髓间充质干细胞(Bone Marrow Mesenchymal Stem Cells, BMSCs)的成骨及成脂分化能力的改变,探讨糖尿病模型骨质疏松形成与BMSCs成骨及成脂分化能力的相关性。方法:利用链脲佐菌素(Streptozotocin, STZ)加高糖高脂饲料诱导制作大鼠糖尿病模型,正常大鼠作为对照组。分别于注射STZ液4、8、12周后,利用全骨髓贴壁法来扩增和纯化BMSCs,取生长良好的第3代细胞作为本实验的研究对象。用成骨诱导液诱导细胞分化,培养7 d后,检测碱性磷酸酶(Alkaline Phosphatase, ALP)活力,14 d后,进行茜素红染色及检测ALP和骨钙素(Osteocalcin, OC) mRNA含量。用成脂诱导液诱导细胞分化,诱导14 d后,进行油红O染色,计算脂肪细胞转化率;进行油红O染色定量分析;检测脂蛋白脂酶(Lipoprotein Lipase, LPL)和过氧化物酶增殖活化受体(Peroxisome Proliferator Activated Receptor, PPARγ2) mRNA含量。结果:注射STZ液8、12周后,糖尿病组ALP活力明显下降,与对照组比较,P < 0.01。对照组钙化结节数量明显多于糖尿病组。ALP基因相对OD值,糖尿病组(0.26 ± 0.05)低于对照组(0.42 ± 0.09),P < 0.01。OC基因相对OD值,糖尿病组(0.31 ± 0.09)低于对照组(0.41 ± 0.06),P < 0.05。注射STZ液4、8、12周后,油红O染色,对照组、糖尿病组镜下观察可见有红色脂滴,对照组脂肪细胞转化率(25.16 ± 5.03)明显低于糖尿病组(66.85 ± 10.01),P < 0.01。油红O染色定量分析结果(OD值),对照组(0.016 ± 0.015)油红含量明显低于糖尿病组(0.058 ± 0.016),P < 0.01。LPL基因相对OD值,糖尿病组(0.89 ± 0.05)高于对照组(0.22 ± 0.05),P < 0.01。PPARγ2基因相对OD值,糖尿病组(0.38 ± 0.03)高于对照组(0.18 ± 0.01),P < 0.01。结论:注射STZ液4周以后,糖尿病大鼠BMSCs成脂分化能力增强;8周以后,成骨分化能力明显下降,可能与骨质疏松的形成有一定的关系。
Abstract: Objective: To study osteogenesis and adipogenesis of bone marrow mesenchymal stem cells (BMSCs) by diabetic rats during different time periods, and discuss the correlation of diabetic osteoporosis model formation and BMSCs osteogenesis and adipogenesis. Method: Using Streptozotocin (STZ) with higher sugar high fat feedstuff induced diabetic rats model, normal rats as control group. BMSCs were amplified and purified by whole bone marrow adherent method at 4, 8 and 12 weeks after STZ injection, and the well-grown third-generation cells were selected as the research object of this experiment. Osteogenic induction was used to induce cell differentiation, detecting Alkaline phosphatase (ALP) activity after 7 d; detecting alizarin red staining and ALP and Osteocalcin (Oste-ocalcin, OC) mRNA levels after 14 d. Adipogenic induction was used to induce cell differentiation, and after 14 d detecting quantitative analysis of oil red O staining and Lipoprotein lipase (LPL) and peroxisome proliferator activated receptor (PPARγ2) mRNA levels. Results: The ALP activity of dia-betes group significantly decreased, compared with control group, P < 0.05. Calcified nodules of normal control group are significantly higher than the diabetes groups. The OD relative value of ALP (0.26 ± 0.05) and OC mRNA (0.31 ± 0.09) is lower than the control group (P < 0.01, P < 0.05). After STZ injection fluid 4, 8, 12 weeks, the adipocyte transformation rate and Oil red O dyeing value of control group is lower than the diabetes group. The OD relative value of LPL (0.89 ± 0.05) and PPARγ2 mRNA (0.38 ± 0.03) is lower than the diabetes group (P < 0.01, P < 0.01). Conclusion: Injec-tion of STZ liquid after 4 weeks, the adipogenesis of diabetic rat BMSCs differentiation capacity in-creased obviously; after 8 weeks, the ossification of diabetic rat BMSCs differentiation capacity de-creased obviously, which may have a certain relationship with the formation of osteoporosis.
文章引用:陈嘉, 余文兰, 马晓莉, 谢淑敏, 刘永伦. 糖尿病大鼠骨髓间充质干细胞成骨和成脂分化的研究[J]. 临床医学进展, 2018, 8(8): 750-759. https://doi.org/10.12677/ACM.2018.88125

参考文献

[1] 高照华. 内分泌代谢疾病相关性骨质疏松的研究进展[J]. 中国实验诊断, 2013, 17(3): 590-593.
[2] Hildebolt, C.F., Pilgram, T.K., Dotson, M., et al. (2004) Estrogen and/or Calcium Plus Vitamin D Increase Mandibular Bone Mass. Journal of Periodontology, 75, 811-816. [Google Scholar] [CrossRef] [PubMed]
[3] Mudda, J.A. and Bajaj, M. (2011) Stem Cell Therapy: A Challenge Toperiodontist. Indian Journal of Dental Research, 22, 132-139. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, Q., Shou, P., Zheng, C., et al. (2016) Fate Decision of Mes-enchymal Stem Cells: Adipocytes or Osteoblasts? Cell Death and Differentiation, 23, 1128-1139. [Google Scholar] [CrossRef] [PubMed]
[5] Kim, J. and Ko, J. (2014) A Novel PPARγ2 Modulator SLZIP Controls the Balance between Adipogenesis and Osteogenesis during Mesenchymal Stem Cell Differentiation. Cell Death and Differentiation, 21, 1642-1655. [Google Scholar] [CrossRef] [PubMed]
[6] Liao, L., Yang, X., Su, X., et al. (2013) Redundant miR-3077-5p and miR-705 Mediate the Shift of Mesenchymal Stem Cell Lineage Commitment to Adipocyte in Osteoporosis Bone Marrow. Cell Death & Disease, 4, Article ID: e600. [Google Scholar] [CrossRef] [PubMed]
[7] Kim, M., Lee, Y.J., Jee, S.C., et al. (2016) Anti-Adipogenic Effects of Sesamol on Human Mesenchymal Stem Cells. Biochemical and Biophysical Research Communications, 469, 49-54. [Google Scholar] [CrossRef] [PubMed]
[8] An, Q., Wu, D., Ma, Y., et al. (2015) Suppression of Evi1 Pro-motes the Osteo Genic Differentiation and Inhibits the Adipogenic Differentiation of Bone Marrow-Derived Mesen-chymal Stem Cells in Vitro. International Journal of Molecular Medicine, 36, 1615-1622. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, C., Meng, H., Wang, X., et al. (2016) Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoblasts and Adipocytes and Its Role in Treatment of Osteoporosis. Medical Science Monitor, 22, 226-233. [Google Scholar] [CrossRef
[10] 万雷, 黄宏兴, 黄红, 等. 补肾健脾活血方含药血清提高过表达Sost转染成骨细胞增殖和碱性磷酸酶活性[J]. 中国组织工程研究, 2018, 22(16): 2461-2466.
[11] 吴怨. 2型糖尿病患者合并骨质疏松的发生率及骨代谢生化指标变化分析[J]. 糖尿病新世界, 2018(6): 38-39.
[12] 何文涛, 余学锋. 糖尿病性骨质疏松发病情况及机制新认识[J]. 诊断学理论与实践, 2018, 17(1): 5-10.
[13] 张燕, 杨秋萍, 赵燕, 等. 2型糖尿病大鼠骨质疏松模型的建立[J]. 中国组织工程研究, 2016, 20(40): 6041-6047.
[14] 王菲, 娄静. 补肾强骨汤治疗糖尿病性骨质疏松大鼠模型疗效研究[J]. 陕西中医, 2018, 39(5): 557-560.
[15] 邹璇, 王兴, 刘洪臣. 间充质干细胞成骨成脂分化在糖尿病骨质疏松中的作用[J]. 口腔颌面修复学杂志, 2016, 17(3): 180-183.
[16] 周宇宁, 马吴迪, 桂志鹏, 等. 糖尿病兔骨髓间充质干细胞成骨分化能力探讨[J]. 中国口腔颌面外科杂志, 2017, 15(2): 103-108.